カテゴリー： 世界, 医療/バイオ, Grand View Research

世界の研究用タンパク質市場（2023-2030）：製品別（サイトカイン・成長因子、抗体）、宿主細胞別（哺乳類細胞、細菌細胞）、エンドユーザー別、地域別

【英語タイトル】Research-grade Proteins Market Size, Share & Trends Analysis Report By Product (Cytokines & Growth Factors, Antibodies), By Host Cell (Mammalian Cells, Bacterial Cells), By End-use, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23NOV164）・商品コード：GRV23NOV164
・発行会社（調査会社）：Grand View Research
・発行日：2023年9月
・ページ数：160
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：バイオテクノロジー
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

研究用タンパク質市場の成長と動向
Grand View Research, Inc.の最新レポートによると、研究用タンパク質の世界市場規模は2030年までに26億9000万米ドルに達し、2023年から2030年までのCAGRは15.53%で成長すると推定されています。がん研究分野での研究開発投資の増加や個別化医薬品に対する需要の高まりが、市場の成長に寄与すると予測されています。また、様々な臨床研究のために多くの国で政府投資が増加していることも、市場の成長を促進すると予想されます。さらに、発展途上国におけるバイオテクノロジー産業の進歩の高まりが、予測期間における市場の成長をさらに後押ししています。

COVID-19パンデミックは、ワクチン、診断薬、治療薬開発のための研究活動の急増により、市場にプラスの影響を与えました。規制当局がワクチン候補の承認プロセスを迅速化することに注力したため、受託製造の需要が増加しました。mRNAワクチンなどの新規ワクチン・プラットフォームは大きな注目を集めましたが、組み換えタンパク質ワクチンの代替品もいくつか評価されています。例えば、2022年7月、ノババックス社のNuvaxovid（NVX-CoV2373）組換えタンパク質ベースのCOVID-19ワクチンは、EUで使用するための拡大条件付き製造販売承認を取得しました。さらに、パンデミックは、生物製剤における機敏で柔軟な製造能力の必要性を浮き彫りにしました。このような要因が競争環境を後押しし、近い将来の市場成長を促進すると期待されています。

Global Genesによると、2019年10月には、世界全体で4億人以上の人々が希少疾患や遺伝病を抱えて生活しています。この数字は、治療法および臨床環境の改善だけでなく、健康意識の切実な必要性を示しています。先進的な研究と創薬ターゲティングメカニズムの知識の必要性は、医薬品開発にとって極めて重要です。多くの地域では、コホート・プログラムからバイオバンクを開発し、研究者に質の高いサンプルを提供することで、治療への取り組みに革命をもたらしています。その結果、様々な疾患に対するバイオマーカー探索への注目が高まると予想されます。このように、より良い医療インフラを構築するための研究活動への取り組みや政府の関心は、研究用タンパク質の応用を強化し、結果として市場の成長を促進すると予想されます。

しかし、タンパク質の生産は時間のかかる作業であり、その作業には多くの場合、作業条件の維持が必要です。このような組換え製品に対する高い需要が増え続けているにもかかわらず、規制機関からの支援はまだゆっくりとしたペースで進展しています。研究用タンパク質は通常、宿主または発現系を介して製造され、目的の製品に特異的な遺伝子がトランスフェクション、細菌形質転換またはウイルス導入の段階を経て発現されます。この複雑なプロセスは、しばしば標的外の領域を過剰発現させるという欠点があり、さらに多くの時間を必要とします。このように、組換え技術に関する特定のガイドラインや規制が存在しないことが、研究用タンパク質市場の活況を妨げる大きな要因となっています。

研究用タンパク質市場レポートハイライト

- 製品別では、サイトカイン＆成長因子セグメントが2022年に23.36％の最大収益シェアで市場を支配し、このセグメントは予測期間中に17.62％の最速CAGRで成長すると予測されています。これは、創薬および薬剤開発のためのさまざまな臨床試験における役割に起因しています。

- 宿主細胞に基づくと、哺乳類細胞セグメントは2022年に55.73%の最大収益シェアで市場を支配しました。この大きなシェアは主に、モノクローナル抗体、ワクチンなどのバイオ医薬品の生産に役立つ、ヒト細胞と同様の生物学的構造によるものです。

- 最終用途別では、製薬・バイオテクノロジー企業が2022年に61.35%の最大シェアを占めました。創薬・医薬品開発のための研究活動の増加や個別化医薬品の需要の高まりにより、研究用タンパク質の需要は予測期間中に増加すると予測されています。

- 地域別では、北米が2022年の収益シェア44.86%で市場を支配しました。この大きなシェアは、大手市場プレイヤーの存在と強固な医療インフラによるものです。これらの要因により、同地域の研究用タンパク質市場は予測期間中に拡大すると予測されます。

第1章. 調査方法・範囲
第2章. エグゼクティブサマリー
第3章. 市場変動・動向・範囲
第4章. 世界の研究用タンパク質市場：製品別予測・動向分析
第5章. 世界の研究用タンパク質市場：宿主細胞別予測・動向分析
第6章. 世界の研究用タンパク質市場：最終用途別予測・動向分析
第7章. 世界の研究用タンパク質市場：地域別予測・動向分析
第8章. 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Research-grade Proteins Market: Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Host Cell Segment
1.2.3. End-use Segment
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Formulation & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Research-grade Proteins Market: Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Research-grade Proteins Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Increasing use of recombinant proteins in research activities
3.3.2. Growing research activities for drug discovery and precision medicine
3.3.3. Rising adoption of biologics & biosimilars
3.4. Market Restraint Analysis
3.4.1. Regulatory and safety concerns regarding protein production
3.4.2. Dearth of skilled personnel and expertise
3.5. Business Environment Analysis
3.5.1. PESTEL Analysis
3.5.2. Porter’s Five Forces Analysis
3.5.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Research-grade Proteins Market: Product Movement Analysis
4.2. Cytokines & Growth Factors
4.2.1. Cytokines & Growth Factors Market, 2018 – 2030 (USD Million)
4.2.2. Interferons (IFNs)
4.2.2.1. Interferons (IFNs) Market, 2018 – 2030 (USD Million)
4.2.3. Interleukins (ILs)
4.2.3.1. Interleukins (ILs) Market, 2018 – 2030 (USD Million)
4.2.4. Others
4.2.4.1. Others Market, 2018 – 2030 (USD Million)
4.3. Antibodies
4.3.1. Antibodies, 2018 – 2030 (USD Million)
4.4. Immune Checkpoint Proteins
4.4.1. Immune Checkpoint Proteins Market, 2018 – 2030 (USD Million)
4.5. Virus Antigens
4.5.1. Virus Antigens Market, 2018 – 2030 (USD Million)
4.6. Enzymes
4.6.1. Enzymes Market, 2018 – 2030 (USD Million)
4.6.2. Kinases
4.6.2.1. Kinases Market, 2018 – 2030 (USD Million)
4.6.3. Metabolic Enzymes
4.6.3.1. Metabolic Enzymes Market, 2018 – 2030 (USD Million)
4.6.4. Others
4.6.4.1. Others Market, 2018 – 2030 (USD Million)
4.7. Recombinant Regulatory Proteins
4.7.1. Recombinant Regulatory Proteins Market, 2018 – 2030 (USD Million)
4.8. Hormones
4.8.1. Hormones Market, 2018 – 2030 (USD Million)
4.9. Others
4.9.1. Others Market, 2018 – 2030 (USD Million)
Chapter 5. Host Cell Business Analysis
5.1. Research-grade Proteins Market: Host Cell Movement Analysis
5.2. Mammalian Cells
5.2.1. Mammalian Cells Market, 2018 – 2030 (USD Million)
5.3. Bacterial Cells
5.3.1. Bacterial Cells Market, 2018 – 2030 (USD Million)
5.4. Yeast & Fungi
5.4.1. Yeast & Fungi Market, 2018 – 2030 (USD Million)
5.5. Insect Cells
5.5.1. Insect Cells Market, 2018 – 2030 (USD Million)
5.6. Others
5.6.1. Others Market, 2018 – 2030 (USD Million)
Chapter 6. End-use Business Analysis
6.1. Research-grade Proteins Market: End-use Movement Analysis
6.2. Pharmaceutical & Biotechnology Companies
6.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 – 2030 (USD Million)
6.3. Academic & Research Institutes
6.3.1. Academic & Research Institutes Market, 2018 – 2030 (USD Million)
6.4. Others
6.4.1. Others Market, 2018 – 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Regional Market Snapshot
7.2. North America
7.2.1. North America Research-grade Proteins Market, 2018 – 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Competitive Scenario
7.2.2.3. Regulatory Scenario
7.2.2.4. U.S. Research-grade Proteins Market, 2018 – 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Competitive Scenario
7.2.3.3. Regulatory Scenario
7.2.3.4. Canada Research-grade Proteins Market, 2018 – 2030 (USD Million)
7.3. Europe
7.3.1. Europe Research-grade Proteins Market, 2018 – 2030 (USD Million)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Scenario
7.3.2.4. UK Research-grade Proteins Market, 2018 – 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Scenario
7.3.3.4. Germany Research-grade Proteins Market, 2018 – 2030 (USD Million)
7.3.4. Spain
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Regulatory Scenario
7.3.4.4. Spain Research-grade Proteins Market, 2018 – 2030 (USD Million)
7.3.5. France
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Scenario
7.3.5.3. Regulatory Scenario
7.3.5.4. France Research-grade Proteins Market, 2018 – 2030 (USD Million)
7.3.6. Italy
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Scenario
7.3.6.3. Regulatory Scenario
7.3.6.4. Italy Research-grade Proteins Market, 2018 – 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Scenario
7.3.7.3. Regulatory Scenario
7.3.7.4. Denmark Research-grade Proteins Market, 2018 – 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Scenario
7.3.8.3. Regulatory Scenario
7.3.8.4. Sweden Research-grade Proteins Market, 2018 – 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Scenario
7.3.9.3. Regulatory Scenario
7.3.9.4. Norway Research-grade Proteins Market, 2018 – 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia-Pacific Research-grade Proteins Market, 2018 – 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Scenario
7.4.2.4. Japan Research-grade Proteins Market, 2018 – 2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Scenario
7.4.3.4. China Research-grade Proteins Market, 2018 – 2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Scenario
7.4.4.4. India Research-grade Proteins Market, 2018 – 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Scenario
7.4.5.4. South Korea Research-grade Proteins Market, 2018 – 2030 (USD Million)
7.4.6. Thailand
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Scenario
7.4.6.4. Thailand Research-grade Proteins Market, 2018 – 2030 (USD Million)
7.4.7. Australia
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Regulatory Scenario
7.4.7.4. Australia Research-grade Proteins Market, 2018 – 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Research-grade Proteins Market, 2018 – 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Scenario
7.5.2.4. Brazil Research-grade Proteins Market, 2018 – 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Scenario
7.5.3.4. Mexico Research-grade Proteins Market, 2018 – 2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Scenario
7.5.4.4. Argentina Research-grade Proteins Market, 2018 – 2030 (USD Million)
7.6. MEA
7.6.1. MEA Research-grade Proteins Market, 2018 – 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Scenario
7.6.2.4. South Africa Research-grade Proteins Market, 2018 – 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Scenario
7.6.3.4. Saudi Arabia Research-grade Proteins Market, 2018 – 2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Scenario
7.6.4.4. UAE Research-grade Proteins Market, 2018 – 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Scenario
7.6.5.4. Kuwait Research-grade Proteins Market, 2018 – 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Share/Position Analysis, 2022
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific, Inc.
8.4.1.1. Company Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Abcam Plc
8.4.2.1. Company Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Miltenyi Biotec
8.4.3.1. Company Overview
8.4.3.2. Product Benchmarking
8.4.3.3. Strategic Initiatives
8.4.4. GenScript
8.4.4.1. Company Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Bio-Techne
8.4.5.1. Company Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Proteintech Group, Inc.
8.4.6.1. Company Overview
8.4.6.2. Product Benchmarking
8.4.6.3. Strategic Initiatives
8.4.7. ACROBiosystems
8.4.7.1. Company Overview
8.4.7.2. Product Benchmarking
8.4.7.3. Strategic Initiatives
8.4.8. Sino Biological, Inc.
8.4.8.1. Company Overview
8.4.8.2. Product Benchmarking
8.4.8.3. Strategic Initiatives
8.4.9. Prospec-Tany Technogene Ltd.
8.4.9.1. Company Overview
8.4.9.2. Product Benchmarking
8.4.9.3. Strategic Initiatives
8.4.10. New England Biolabs
8.4.10.1. Company Overview
8.4.10.2. Product Benchmarking
8.4.10.3. Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 North America research-grade proteins market, by country, 2018 - 2030 (USD Million)
Table 4 North America research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 5 North America research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 6 North America research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 7 U.S. research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 8 U.S research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 9 U.S research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 10 Canada research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 11 Canada research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 12 Canada research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 13 Europe research-grade proteins market, by country, 2018 - 2030 (USD Million)
Table 14 Europe research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 15 Europe research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 16 Europe research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 17 UK research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 18 UK research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 19 UK research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 20 Germany research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 21 Germany research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 22 Germany research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 23 France research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 24 France research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 25 France research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 26 Italy research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 27 Italy research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 28 Italy research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 29 Spain research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 30 Spain research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 31 Spain research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 32 Denmark research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 33 Denmark research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 34 Denmark research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 35 Sweden research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 36 Sweden research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 37 Sweden research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 38 Norway research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 39 Norway research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 40 Norway research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 41 Asia Pacific research-grade proteins market, by country, 2018 - 2030 (USD Million)
Table 42 Asia Pacific research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 43 Asia Pacific research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 44 Asia Pacific research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 45 China research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 46 China research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 47 China research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 48 Japan research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 49 Japan research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 50 Japan research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 51 India research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 52 India research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 53 India research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 54 South Korea research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 55 South Korea research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 56 South Korea research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 57 Australia research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 58 Australia research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 59 Australia research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 60 Thailand research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 61 Thailand research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 62 Thailand research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 63 Latin America research-grade proteins market, by country, 2018 - 2030 (USD Million)
Table 64 Latin America research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 65 Latin America research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 66 Latin America research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 67 Brazil research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 68 Brazil research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 69 Brazil research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 70 Mexico research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 71 Mexico research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 72 Mexico research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 73 Argentina research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 74 Argentina research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 75 Argentina research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 76 Middle East & Africa research-grade proteins market, by country, 2018 - 2030 (USD Million)
Table 77 Middle East & Africa research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 78 Middle East & Africa research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 80 South Africa research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 81 South Africa research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 82 South Africa research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 85 Saudi Arabia research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 86 UAE research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 87 UAE research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 88 UAE research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 89 Kuwait research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 90 Kuwait research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 91 Kuwait research-grade proteins market, by end-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Market summary
Fig. 4 Market segmentation & scope
Fig. 5 Market size and growth prospects
Fig. 6 Global research-grade proteins market- Key market driver analysis
Fig. 7 Global research-grade proteins market - Key market restraint analysis
Fig. 8 Global research-grade proteins market - Porter’s analysis
Fig. 9 Global research-grade proteins market - PESTEL analysis
Fig. 10 Global research-grade proteins market: Product outlook key takeaways
Fig. 11 Global research-grade proteins market: Product movement analysis
Fig. 12 Cytokines & growth factors market estimates, 2018 - 2030 (USD Million)
Fig. 13 Interferons (IFNs) market estimates, 2018 - 2030 (USD Million)
Fig. 14 Interleukins (ILs) market estimates, 2018 - 2030 (USD Million)
Fig. 15 Others market estimates, 2018 - 2030 (USD Million)
Fig. 16 Antibodies market estimates, 2018 - 2030 (USD Million)
Fig. 17 Immune checkpoint proteins market estimates, 2018 - 2030 (USD Million)
Fig. 18 Virus antigens market estimates, 2018 - 2030 (USD Million)
Fig. 19 Enzymes market estimates, 2018 - 2030 (USD Million)
Fig. 20 Kinases market estimates, 2018 - 2030 (USD Million)
Fig. 21 Metabolic enzymes market estimates, 2018 - 2030 (USD Million)
Fig. 22 Others market estimates, 2018 - 2030 (USD Million)
Fig. 23 Recombinant regulatory proteins market estimates, 2018 - 2030 (USD Million)
Fig. 24 Hormones market estimates, 2018 - 2030 (USD Million)
Fig. 25 Others market estimates, 2018 - 2030 (USD Million)
Fig. 26 Global research-grade proteins market: Host cells outlook key takeaways
Fig. 27 Global research-grade proteins market: Host cells movement analysis
Fig. 28 Mammalian cells market estimates, 2018 - 2030 (USD Million)
Fig. 29 Bacterial cells market estimates, 2018 - 2030 (USD Million)
Fig. 30 Yeast & fungi market estimates, 2018 - 2030 (USD Million)
Fig. 31 Insect cells market estimates, 2018 - 2030 (USD Million)
Fig. 32 Others market estimates, 2018 - 2030 (USD Million)
Fig. 33 Global research-grade proteins market: End-use outlook key takeaways
Fig. 34 Global research-grade proteins market: End-use movement analysis
Fig. 35 Pharmaceutical & biotechnology companies market estimates, 2018 - 2030 (USD Million)
Fig. 36 Academic & research institutes market estimates, 2018 - 2030 (USD Million)
Fig. 37 Others market estimates, 2018 - 2030 (USD Million)
Fig. 38 Regional marketplace: Key takeaways
Fig. 39 Global research-grade proteins market: Regional movement analysis
Fig. 40 North America research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 41 U.S. research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 42 Canada research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 43 Europe research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 44 UK research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 45 Germany research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 46 France research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 47 Spain research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 48 Italy research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 49 Denmark research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 50 Sweden research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 51 Norway research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 52 Asia Pacific research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 53 Japan research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 54 China research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 55 India research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 56 South Korea research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 57 Australia research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 58 Thailand research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 59 Latin America research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 60 Brazil research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 61 Mexico research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 62 Argentina research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 63 MEA research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 64 South Africa research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 65 Saudi Arabia research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 66 UAE research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 67 Kuwait research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 68 Strategy framework

★調査レポート[世界の研究用タンパク質市場（2023-2030）：製品別（サイトカイン・成長因子、抗体）、宿主細胞別（哺乳類細胞、細菌細胞）、エンドユーザー別、地域別] (コード：GRV23NOV164)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の研究用タンパク質市場（2023-2030）：製品別（サイトカイン・成長因子、抗体）、宿主細胞別（哺乳類細胞、細菌細胞）、エンドユーザー別、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の組換えタンパク質市場（2023-2033)：製品・サービス別（サイトカイン・成長因子、抗体、酵素、その他）、用途別（生物製剤生産、創薬・開発、研究、診断、その他）、宿主細胞別（哺乳類系、細菌細胞、酵母・菌類、昆虫細胞、その他）、エンドユーザー別（バイオ医薬品・バイオテクノロジー企業、その他）、地域別
  • 細胞溶解・破砕のグローバル市場2023-2030：哺乳類細胞、細菌細胞、酵母/藻類/菌類、植物細胞
  • 細胞溶解キットのグローバル市場2023年：哺乳類細胞、細菌細胞、その他
  • 世界の細胞溶解・破砕市場2022-2032：技術別（試薬ベース、物理的破砕）、製品種類別（機器、試薬・消耗品）、細胞種類別（哺乳類細胞、細菌細胞、酵母/藻類/菌類、植物細胞）、用途別（タンパク質単離、ダウンストリーム処理、細胞オルガネラ単離、核酸分離）、地域別
  • 組換えタンパク質のグローバル市場（2023-2030）：接着分子＆受容体、成長因子＆ケモカイン、免疫応答タンパク質

    • ◆H&Iグローバルリサーチのお客様（例）◆